Human BCA-1/BLC (CXCL13)

BCA-1/BLC (CXCL13), human recombinant
A cytokine selectively chemotactic for B cells
Product Overview
Alternate Names / Synonyms: Human BCA-1/BLC (CXCL13), BCA-1, BCA1, BCA 1, BLC(CXCL13), BLC, CXCL13, h-BLC, rh-BLC, h-BCA-1, rh-BCA-1, rh-CXCL13, recombinant human BCA-1
Gene Symbol: CXCL13
Accession #: O43927
Gene ID: 10563
Source: E. coli
Appearance: Lyophilized protein
Physical Form Description: Sterile filtered and lyophilized from 10 mM TFA
Molecular Weight: 10.1 kDa
Purity by SDS-PAGE: ≥95%
Purity by HPLC: ≥95%
Endotoxin Level: <0.1 ng/μg
Biological Activity: Determined by its ability to chemoattract human B cells using a concentration range of 1.0-10 ng/ml.
Reconstitution Instructions: Centrifuge the vial prior to opening. Reconstitute in water to a concentration of 0.1-1 mg/ml. The solution can then be diluted into other aqueous buffers or store at 4°C for 1 week or -20°C for future use.
Storage Temp.: -20°C
Shipping: Gel pack
Background Information: Human BCA-1 (B Cell-Attracting chemokine 1), also known as BLC or CXCL13, is a recently identified new CXC chemokines. Human BCA-1 is a highly effective attractant for human blood B lymphocytes, but was inactive on freshly isolated or IL-2 stimulated T lymphocytes, monocytes and neutrophils. The human BCA-1 is a 10.1 kDa protein containing 85 amino acid residues.
Handling: Centrifuge the vial prior to opening.
Usage: For Research Use Only! Not to be used in humans.